MedPath
NMPA Approval

Cetirizine Hydrochloride Eye Drops

国药准字H20244893

September 10, 2024

Drug Information

盐酸西替利嗪滴眼液

眼用制剂

0.2ml:0.48mg(按C₂₁H₂₅ClN₂O₃计)

化学药品

September 10, 2024

Company Information

Applicant Company

苏州市吴中区郭巷街道尹中南路1858 号

Manufacturing Company

苏州市吴中区郭巷街道尹中南路1858号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.